Wantstats
IndustriesCompaniesCharts & Stats
Leads DBAdvisoryPricingContact us
Login
/Company Profiles

Deep Intelligence Across Industries

All CompaniesFortune 500Aerospace & Defense iconAerospace & DefenseAgricultureAutomotive iconAutomotiveFinancial Services iconFinancial ServicesChemicals & Materials iconChemicals & MaterialsConsumer Goods iconConsumer GoodsEnergy & Power iconEnergy & PowerEquipment & Machinery iconEquipment & MachineryFood & Beverages iconFood & BeveragesHealthcare & Pharma iconHealthcare & PharmaInformation Technology iconInformation TechnologyManufacturing & ConstructionMRO iconMROProfessional Services iconProfessional ServicesSemiconductors

Showing 14441 companies

Richest

Richest Group Limited

Premium
Chemicals & Materials

Company Headquarters: Shanghai, China Founded: 1996 Workforce: ~500 Company Working: Richest Group Limited (Richest Group) is a major global chemical manufacturer and supplier. It primarily operates through segments such as alloy products, OLED intermediate, rare earth product, amino acids, rubber and plastic, food additives, pesticide, solvent, inorganic salt, plant extract, water treatment, and other products. Under the other products segment, it manufactures manganese dioxide, furfuryl alcohol, VAE emulsion, sodium hydroxide, bromoethane, and pine oil, among others. It has international trade relations with major companies in the US, Germany, South Korea, Japan, New Zealand, Chile, and India, among others. It has two R&D laboratories in Shanghai and Wuhan, and three production sites in Zhejiang, Jiangsu, and Shandong.

RevenueN/A
Employees500
Market CapN/A
Founded1996
Shanghai, China
Benson

Benson Polymers Limited

Premium
Chemicals & Materials

Company Headquarters: New Delhi, India Founded: 1992 Workforce: ~73 Company Working: Benson Polymers Limited (Benson) is a leading manufacturer and exporter of a wide range of adhesive products. It provides a varied range of well-known consumer and industrial brands of adhesives. It operates through various product segments, namely cyanoacrylate adhesive, CA glue non-blooming, instant wood glue, wood seal, PVC door and window glue, finger nail glue, cyanoacrylate adhesive in gel, consumer pack CA glue, and water-based emulsion. Under the water-based emulsion segment, it provides wood emulsion and VAE emulsion. It supplies the products to various end-use industries such as adhesives and sealant, paints and coatings, and construction.

RevenueN/A
Employees73
Market CapN/A
Founded1992
New Delhi, India
U.S.

U.S. Adhesives, Inc.

Premium
Chemicals & Materials

Company Headquarters: Chicago, US Founded: 1937 Workforce: ~50 Company Working: U.S. Adhesives, Inc. is one of the leading adhesives manufacturers and suppliers in the country. It is an adhesive formulator of varied range of adhesive and glue products and customizes products according to customer’s specific requirements. It operates through four segments, namely water-based resins, animal glues, hot melt, and dextrin. Under the water-based resins segment, it manufactures VAE emulsion, PVA emulsion, acrylics, SBR latex, natural rubber adhesives, and construction adhesives sealers and coatings. These products serve various end-use industries such as construction, packaging, and book binding.

RevenueN/A
Employees50
Market CapN/A
Founded1937
Chicago, US

Unlock Verified Contacts

Access verified employee contacts

Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.

USD650/mo
Buy Now

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
MR
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
BL
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
MI
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
RK
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
JL
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
AM
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Wantstats logo

Move faster. Think smarter. Win bigger.

Join our data driven community.

© 2026 All rights reserved by Wantstats Research and Media Pvt Ltd

footer vector

Pages

  • About
  • News
  • Charts & Stats
  • Contact
  • Ecosystem pricing
  • Privacy policy

Address

Wantstats Research and media Pvt. Ltd, Office No 104, Pentagon 4,
Magarpatta City, Pune - 411028,
Maharashtra, India.

Contact

support@wantstats.com

Follow Us

Follow Wantstats on FacebookFollow Wantstats on InstagramFollow Wantstats on LinkedInFollow Wantstats on YouTubeFollow Wantstats on WhatsApp
Shanxi

Shanxi Sanwei Group Co., Ltd.

Premium
Chemicals & Materials

Company Headquarters: Shanghai, China Founded: 1970 Workforce: >1,000 Company Working: Shanxi Sanwei Group Co, Ltd. (Shanxi Sanwei) is one of the major manufacturers of organic chemical products in China and sells its products largely in the country. It operates through various segments, namely polyvinyl alcohol, sodium diacetate, tetrahydrofuran, gamma-butanediol, VAE emulsion, white emulsion, re-dispersible emulsion powder, and polytetramethylene ether glycol. It has established a 50,000 tons per year VAE emulsion plant by adopting domestic and international advanced technology. Their products are widely used in the building and construction, textile, and wood processing industries, among others. Shanxi Sanwei exports its products to around 100 countries across the globe.

RevenueN/A
Employees1,000
Market CapN/A
Founded1970
Shanghai, China
Dairen

Dairen Chemical Corporation

Premium
Chemicals & Materials

Company Headquarters: Taiwan, China Founded: 1979 Workforce: ~928 Company Working: Dairen Chemical Corporation (DCC) is a joint venture between Chang Chun Group (Chang Chun Petrochemical and Chang Chun Plastics) and Nan Pao Resins. It is one of the leading producers of VAE emulsion and is primarily engaged in the manufacturing and supply of vinyl acetate monomer (VAM) used to produce polyvinyl alcohol (PVA) and polyvinyl acetate (PVAc). DCC operates through two segments, namely ethylene product and propene product. Under the ethylene product segment, it manufactures VAM, VAE copolymer emulsion, ethylene-vinyl acetate-vinyl chloride emulsion, ethylene-vinyl chloride emulsion, vinyl acetate-ethylene re-dispersible powder, nitrogen, and liquefied carbon dioxide. DCC has three production sites in Taiwan, one in Malaysia, and one in China

RevenueN/A
Employees928
Market CapN/A
Founded1979
Taiwan, China
Shenzhen

Shenzhen New Industries Biomedical Engineering Co., Ltd

Premium
Healthcare

Company Headquarters: China Founded: 1995 Workforce: ~ 812 Company Working: SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD is a leading analytical company that focuses on improving the quality performance of clients and customers. It also provides analytical solutions that help payers to achieve their business objectives. It serves analytical solutions to 25 players in the US healthcare market. It is one of the leading providers of analytics-driven payment accuracy and management solutions worldwide. It is primarily focused on the healthcare sector.

RevenueN/A
Employees812
Market CapN/A
Founded1995
China
Regulus

Regulus Therapeutics, Inc.

Premium
Healthcare

Company Headquarters: California, US Founded: 2007 Company Working: Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company engaging in the discovery and development of drugs that target microRNAs to treat a range of diseases in the US and Europe. Its two lead products include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease and RGLS4326, an anti-miR targeting miR-17, which is in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for Hepatitis B virus, NASH, and other infectious diseases.

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded2007
California, US
Prometheus

Prometheus Laboratories Inc.

Premium
Healthcare

Company Headquarters: California, US Founded: 1995 Company Working: Prometheus Laboratories Inc. (Prometheus) is engaged in the development and commercialization of pharmaceutical and diagnostic products that enable physicians to provide individualized patient care. The company offers Anser IFX and Anser ADA monitoring assays, non-invasive tests, and inflammation markers in the smart diagnostic algorithm for added diagnostic clarity, celiac tests, and thiopurine monitoring tests, among others. Prometheus operates as a subsidiary of Nestlé.

Revenue$87.3B
EmployeesN/A
Market CapN/A
Founded1995
California, US
Echosens

Echosens

Premium
Healthcare

Company Headquarters: Paris, France Founded: 2001 Workforce: ~9000 (2018) Company Working: Echosens develops, manufactures, and markets non-invasive diagnostic products and services in the field of hepatology. The company offers FibroScan, which is based on proprietary vibration controlled transient elastography technology and is used in routine clinical practice and research; FibroMeter range that provides blood tests; and FibroView, which offers smart connectivity software solutions linking FibroScan to the hospital information systems. Echosens currently possesses more than 22 patent families. The company has six subsidiaries in Germany, Hong Kong, Spain, China, Lebanon, and the US.

RevenueN/A
Employees9,000
Market CapN/A
Founded2001
Paris, France
Cisbio

Cisbio

Premium
Healthcare

Company Headquarters: Codolet, France Founded: 1985 Company Working: Cisbio is a life sciences company involved in the manufacturing of assays and reagents. It offers kits and reagents to address the G protein-coupled receptor activation pathway, cellular protein assays, non-phosphorylated proteins assays, and receptor binding assays, among others. The company provides its products for various therapeutic areas, including cardiovascular, infectious diseases, inflammation/immunology, metabolism/diabetes, neurosciences, oncology, and rare diseases. It has its facilities in France, the US, and China, as well as a network of sales offices and distributors across the globe. As Cisbio operates as a subsidiary of PerkinElmer, Inc., the financials mentioned are of the parent company.

Revenue$2.1B
EmployeesN/A
Market CapN/A
Founded1985
Codolet, France
Broadcom

Broadcom

Premium
ICT

Broadcom Inc. (Broadcom) provides a range of semiconductors, including complex digital and mixed-signal complementary metal oxide semiconductor (CMOS)-based devices and analog III-V-based products. It operates through four segments—wired infrastructure, wireless communications, enterprise storage, and industrial & others. The wired infrastructure segment provides a broad set of standard Ethernet switching technologies to deliver system-on-chips (SoCs) for high-performance computing applications and high-speed serializer/deserializer technology integrated with application-specific integrated circuits (ASICs). It also offers semiconductor solutions for set-top boxes, digital subscriber line cable, and fiber broadband access markets. The segment also provides transceivers that transmit and receive Ethernet data packets through copper wires or optical fiber cables. Broadcom provides optical laser and receiver components for Ethernet networking and access, metro, and long-haul telecommunication networks. The wireless communication segment offers a variety of radio frequency (RF) semiconductor devices that amplify and filter RF signals. The enterprise storage segment offers products designed to enable secure movement of digital data to and from host machines, such as servers, personal computers, and storage systems, to underlying storage devices including hard disk drives (HDDs) and solid-state drives (SSDs). The products offered by the company include enterprise and data center networking, home connectivity, broadband access, telecommunications equipment, smartphones, data center servers and storage, factory automation, power generation and alternative energy systems, and electronic displays. Geographically, the company operates in the US, China, and Singapore, among others.

Revenue$17.6B
Employees20,000
Market Cap$1874.0B
Founded1991
United States, North America
Juniper

Juniper Networks

Premium
ICT

Juniper Networks, Inc. engages in the sales of products and services, design, and development, for high-performance networks. The company operates in various business segments, including switching, routing, and security products, which are designed to provide high performance, flexibility, and low total ownership cost. The company operates across more than 100 countries in EMEA, the Americas, and Asia-Pacific. Few subsidiaries of Juniper Networks are AppFormix Inc, Cyphort Inc., WANDL Inc., and Altor Networks. The major competitors of Juniper Networks are Cisco Systems, Arista Networks, Hewlett Packard Enterprise, Alcatel-Lucent Enterprise, and Huawei Technologies Co. Ltd. The company operates globally.

Revenue$5.0B
Employees9,419
Market CapN/A
Founded1996
United States, North America
Star

Star Union Dai-ichi Life Insurance Co. Ltd.

Premium
Healthcare

Company Headquarters: India (Mumbai) Founded: 2009 Workforce: ~5000 Company Working: Star Union Dai-ichi Life Insurance (SUD Life) is one of the largest insurance companies formed by the joint venture between two of India's leading public sector banks, Bank of India and Union Bank of India, and Dai-ichi Life Holdings, a leading life insurance company in Japan. SUD Life has strong life insurance distribution footprints in India, with 11,000 branches catering to around 65 million customers in the country.

RevenueN/A
Employees5,000
Market CapN/A
Founded2009
India (Mumbai)
Huaxia

Huaxia Life Insurance Co., Ltd

Premium
Healthcare

Company Headquarters: Shanghai Founded: 2006 Workforce: ~10,000 Company Working: Huaxia Life Insurance Co. is an insurance provider company that offers different types of insurance services, which include health, financial, life, pension, accident, and children insurance services. It also provides group insurance and intermediary agent services. Currently, Huaxia Life Insurance Co. has 24 affiliated companies, with a total of 673 branches across the globe.

RevenueN/A
Employees10,000
Market CapN/A
Founded2006
Shanghai
Lupin

Lupin

Premium
Healthcare

Company Headquarter: Mumbai, India Founded: 1968 Workforce: 15,000+ Company Working: Lupin is a global pharmaceutical company that deals in a wide range of products such as branded and generic formulations, biotechnology products, APIs, and specialty drugs. The company is a prominent player in the therapeutic segment such as gynecology, cardiovascular, diabetology, asthma, pediatric, central nervous system, gastrointestinal (GI), anti-infective (AI), and non-steroidal anti-inflammatory drugs (NSAIDS). Also, it has a global leader in the fields of the anti-TB and Cephalosporin segment. Lupin has a presence in more than 100 countries. It has 18 manufacturing facilities, located in many parts of India, Japan, the US, Mexico, and Brazil. All these facilities are benchmarked to international standards to meet stringent quality standards. Also, these facilities are approved by international agencies such as the US FDA, UK MHRA, Japan’s MHLW, TGA Australia, WHO, and the MCC South Africa.

Revenue$2.0B
Employees15,000
Market CapN/A
Founded1968
United States, North America
Kleindiek

Kleindiek Nanotechnik GmbH

Premium
Healthcare

Company Headquarters: Reutlingen, Germany Founded: 1998 Workforce: ~10 Company Working: Kleindiek Nanotechnik GmbH (Kleindiek Nanotechnik) is actively engaged in the development, manufacturing, and distribution of nanotechnology products in the global market. It manufactures probeworkstations, nanoworkstations, micromanipulators, plug-in tools, cryo liftout system, superflat AFM, lift-out shuttle, substages, add-on tools, phenom tools, life science products, software, and consumables. The company has installed more than 3,000 systems across the globe. It develops standardized products for various applications and also designs products as per the needs of companies in the semiconductor technology, optics, micro-mechanics, medicine, and gene- and biotechnology industries.

RevenueN/A
Employees10
Market CapN/A
Founded1998
Reutlingen, Germany
Imina

Imina Technologies SA.

Premium
Healthcare

Company Headquarters: Lausanne, Switzerland Founded: 2009 Workforce: ~11–50 Company Working: Imina Technologies SA. (Imina Technologies) is a prominent player in the global nanobots/nanorobots market. The company is engaged in the development, manufacturing, and distribution of solutions related to microscopy. It operates through the solutions, software’s, and options segments. It has established presence in the European market and offers its products to scientists and researchers. The company generates maximum revenue from its flagship solution miBot, which is used in positioning, handling, and sensing at micro and nanoscales.

RevenueN/A
Employees50
Market CapN/A
Founded2009
Lausanne, Switzerland
Ginkgo

Ginkgo Bioworks

Premium
Healthcare

Company Headquarters: Boston, US Founded: 2008 Workforce: ~300+ Company Working: Ginkgo Bioworks is one of the renowned companies in the life sciences industry. Over the past decade, the particular focus of the company has been on offering innovative solutions in the field of biotechnology, including the development and manufacturing of cultured ingredients, biological engineering, metabolic engineering, and genetically modified organisms. Recently, Ginkgo Bioworks raised more than USD 350 million and with this the company’s valuation crossed USD 4000 million. Ginkgo Bioworks conducts its manufacturing activities through four facilities located in the US.

RevenueN/A
Employees300
Market CapN/A
Founded2008
Boston, US
Synthace

Synthace Limited

Premium
Healthcare

Company Headquarters: London, UK Founded: 2011 Workforce: ~51–200 Company Working: Synthace Limited (Synthace) is into the development of innovative technologies for the manufacturing sector to enhance the increasing the efficiency of the processes. Its specialties are synthetic biology, engineering biology, and programming. Its Antha platform is renowned for extraordinary quality and outstanding results. The company aims to achieve and discover the needs of various sectors and work in line to help the healthcare, food, and energy industries to achieve the desired results. The company marks presence in Europe and the Americas.

RevenueN/A
Employees200
Market CapN/A
Founded2011
London, UK
Zymergen

Zymergen

Premium
Healthcare

Company Headquarters: Emeryville, US Founded: 2013 Workforce: ~201–500 Company Working: Zymergen is a biotechnology and pharmaceutical company engaged in R&D, manufacturing, and marketing of novel products and materials for the agricultural, chemical, materials, pharmaceutical, electronics, and personal care industries. The company operates through two business segments, namely technology and solutions. It uses artificial intelligence, big data, bioinformatics, machine learning, and robotic tools for the development of innovative microbes. The company has an additional office in Washington. It has raised more than USD 500 million in the last 5 years through more than 23 investors by multiple rounds of funding.

RevenueN/A
Employees500
Market CapN/A
Founded2013
Emeryville, US
Brandt

Brandt

Premium
Chemicals & Materials

BRANDT is a second-generation, family-owned agricultural inputs group from central Illinois that combines two different businesses. The first is a regional, direct-to-grower agronomy retailer selling fertilizer, crop protection, seed and custom application through 18 outlets in the Corn Belt. The second is a proprietary specialty-formulations manufacturer selling foliar micronutrients, adjuvants, planter-box products, biologicals and turf nutrition through distributors in more than 80 countries. The retail arm provides scale, cash flow and a field laboratory; the specialty arm provides margin, brand and international growth. Under Rick Brandt, CEO since 1995, the group has grown mainly through acquisition (17 deals by 2022) and plant investment, with production in the US, Brazil and Spain. It competes with far larger listed groups, and its edge rests on formulation know-how, a recognisable brand, and the decision speed of a private owner. Its limits are scale, disclosure and exposure to the farm cycle. A precise latest headcount and a three-year trend are not publicly disclosed. --- **Company's own description.** BRANDT does not publish an annual report. Its standing press-release boilerplate describes it as a leading agricultural company serving growers around the globe, founded in 1953 to help Illinois farmers adopt new and profitable technologies, and now focused on products and services that give growers the best chance of a return. Recent releases describe it as a leading agriculture retailer and manufacturer of specialty agriculture products. **Independent characterisation.** BRANDT is a hybrid distributor-manufacturer. Its 2015 brochure described three complementary businesses, and the current structure is broadly as follows. **BRANDT Agronomic Services (retail):** Sells commodity and branded crop inputs plus application services to farmers in central Illinois. CropLife's profile for the 2023 data year gives the retail sales mix as fertilizer 48%, crop protection 26%, seed 20% and custom application 6%. **BRANDT Specialty Formulations (manufacturing):** Develops, formulates and markets proprietary specialty inputs under the BRANDT brand, sold business-to-business through ag retailers and distributors in the US. **BRANDT International:** Sells and, in Brazil and Spain, manufactures the specialty range outside the US and Canada. Products are available in 80–85 countries (company and trade press, 2025–26). **Adjacent lines:** Turf and ornamental nutrition, planter-box seed lubricants (BRANDT Planting Solutions, formerly Talc USA), and a dealer-support function serving other retailers. **Revenue model.** Revenue is overwhelmingly product sales. Service revenue is limited to custom application (about 6% of retail sales). No subscription or licensing revenue is disclosed. **Value chain position.** BRANDT sits downstream of basic fertilizer and active-ingredient producers. In retail it is the last link before the farm. In specialty it is a formulator and brand owner that sells through third-party retail. **Customers and end-markets.** Row-crop farmers in Illinois and Iowa (corn, soybeans); US ag retailers and distributors; specialty crop growers (fruit, nuts, vegetables, citrus) in California and Florida; organic growers (more than 50 OMRI-listed products per trade press); golf, sports turf and ornamental customers; and international distributors.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1953
Illinois, US
Zwack

Zwack Unicum Nyrt.

Premium
Information Technology

Zwack Unicum is Hungary's largest branded spirits company and the custodian of Unicum, a bitter herbal liqueur widely regarded as one of Hungary's national drinks. The company is family-controlled and has been listed in Budapest since 1993. It combines two businesses. The first is a high-margin portfolio of its own brands: Unicum and its line extensions, St. Hubertus, Fütyülős, Kalumba gin, Vilmos, Kalinka and others. The second is a distribution arm that until 31 December 2026 holds the exclusive Hungarian mandate for Diageo's spirits. The model is asset-light and debt-free, and close to 100% of earnings are paid out as dividends. Domestic demand drives almost 90% of product revenue, so results are highly sensitive to Hungarian real wages, excise policy and retail-trade regulation. The defining event of 2026 is Diageo's decision to award its Hungarian distribution to another party. That decision removes about one-fifth of revenue and, by management's estimate, about 15% of profit from FY2028. Zwack's strategy is pivoting towards Unicum-led innovation, export growth and new third-party brands. --- ### Company's own description In its FY2026 and Q1 FY2027 management reports, the company describes its primary activity as the production and sale of branded premium and quality alcoholic drinks [S4]. It states that its principal aim is to defend its market-leading position in Hungarian spirits while strengthening its export markets. It also positions itself as the official domestic distributor of several international brands, chiefly the Diageo spirits portfolio. Combining its own brands (Unicum, Fütyülős, Kalumba, Vilmos, St. Hubertus, Kalinka) with global brands (Johnnie Walker, Baileys, Captain Morgan, Tanqueray, Smirnoff, Don Papa), it says, gives consumers an unusually broad choice [S4]. Management identifies product innovation and successful product launches as the key tools for defending its leadership. It also claims the largest sales and marketing workforce in the Hungarian spirits market [S3][S4]. ### Independent characterisation Zwack is best understood as three interlocking economic engines. 1. **Own-produced spirits (about 74% of FY2026 product revenue).** This engine covers the Unicum brand family, the "quality" tier (St. Hubertus, Kalinka and others) and exports. It carries the margin. In Q1 FY2027 own-produced products generated HUF 1,002m of operating profit, against HUF 72m from traded products [S4]. Gross margin on the total business was 64.6% in FY2026, and the own-brand mix is what drives it [S1]. 2. **Third-party distribution (about 22% of FY2026 product revenue).** This engine is predominantly Diageo, with smaller lines in mineral water (Evian), Prosecco and wines. It adds scale to the sales force, gives Zwack negotiating weight with retailers and on-trade customers, and supports the fixed cost base. Its stand-alone margins are thin and have sometimes been negative at quarterly level: traded products lost HUF 49m at the operating level in Q1 FY2026 [S4]. 3. **Services (about 4.5% of FY2026 revenue).** This is mainly reimbursement from brand owners (Diageo Scotland Ltd.) for marketing that Zwack performs on their brands. It amounted to HUF 1,091m in FY2026 [S1]. **Revenue model.** Product sales account for about 95.5% of revenue and services/marketing reimbursements for about 4.5%. There is no subscription or licensing revenue. **Value-chain position.** Zwack is vertically integrated in its own brands. It handles herbal maceration and distillation, cask ageing at Soroksári út, further ageing and bottling at Dunaharaszti, and fruit-brandy and gin distillation at Kecskemét. It then runs brand marketing and wholesale distribution in Hungary. For Diageo brands it acts as importer, wholesaler and marketing agent. **Customer types.** Customers are Hungarian retail chains (off-trade), wholesalers that serve the on-trade (gastronomy), duty-free operators and foreign importers or distributors. Before COVID, the on-trade generated roughly half of domestic sales [S25]. Receivables are 95% credit-insured. The share of receivables held by the single largest counterparties (balances above 10%) was 19.4% at end-FY2026, down from 30.7% a year earlier [S1]. **End-markets.** About 90% of product revenue comes from Hungarian beverage-alcohol consumption [S4]. Exports go mainly to Italy, Germany, Romania and Slovakia, plus duty free, with smaller volumes to North America [S4].

RevenueN/A
Employees259
Market CapN/A
Founded1840
United States, North America
ZuleikaGold

Zuleika Gold Limited

Premium
Information Technology

Zuleika Gold is a Perth-based, single-segment gold exploration company whose value rests on three pillars: a large, under-explored tenement position (roughly 220 km² on the Zuleika Shear plus around 20 km of strike on the parallel Carnage Shear) in the Kundana–Ora Banda district northwest of Kalgoorlie, a district that has historically produced more than 20 million ounces; two small JORC (2012) Mineral Resources totalling about 35,100 ounces (Credo Well 22,500 oz at 2.43 g/t and Paradigm East 12,600 oz at 1.36 g/t); and an unusually liquid balance sheet created by the November 2025 settlement of its five-year Plutonic/K2 litigation against Catalyst Metals, which delivered A$48 million in cash and Catalyst shares. Post-settlement, Zuleika's cash and listed investments exceed its market capitalisation, so the market has historically ascribed little or negative value to its exploration assets. That valuation gap is now being crystallised through a scrip merger into CZR Resources. --- ### What the company does Zuleika Gold explores for gold in the Eastern Goldfields of Western Australia. It holds no producing assets, sells no gold, and generates no operating revenue. Its only recurring income is interest on cash deposits (A$334,367 in FY2026; A$78,201 in FY2025). In FY2026 it recorded a one-off A$48.0 million "other income" item from the litigation settlement, which converted a historically loss-making profile into a A$39.1 million net profit. ### Company's own description (FY2026 Annual Report, paraphrased) The FY2026 Operations Report describes Zuleika as a gold exploration company with high-quality projects near Kalgoorlie, aiming either for discovery or for acquisition of gold projects capable of rapid development. Its principal focus is the Zuleika Shear in the Kundana–Ora Banda district. It holds two project areas, both within trucking distance of established third-party processing plants: the Zuleika Gold Project (hosting the Paradigm East deposit and a pipeline of targets) and the Credo Project (hosting the Credo Well deposit). The stated strategy is to systematically advance the two JORC resources towards development while generating and testing new targets, using sensitive soil geochemistry, first-pass aircore drilling, then reverse circulation (RC) and diamond drilling where warranted. The objective is to grow resources to a scale supporting development, either standalone or via toll treatment at regional mills. The Chair's letter adds that the company continued to assess acquisitions of advanced projects with near-term production potential. ### Business model and revenue model | Dimension | Characterisation | |---|---| | Business model | Pure-play exploration and resource development; value creation via discovery, resource growth, project sale/joint venture, or toll-treatment development | | Revenue model | No product, service, subscription or licensing revenue. 100% of FY2026 revenue (as reported) was interest income; the A$48.0m settlement is classified as other income | | Product vs service mix | Not applicable (pre-production) | | Value chain position | Upstream: greenfield/brownfield exploration and early resource definition. Any future production would likely be outsourced to third-party processing plants (toll treatment) | | Customer types | None currently. Prospective counterparties for any ore would be regional mill owners (e.g., operators of Paddington, Kundana-area and other Kalgoorlie plants) | | End-markets | Gold (global bullion market, priced in USD) | | Funding model | Historically equity placements (e.g., A$6m Dec 2020, A$3m Jan 2022 to Mark Creasy, A$3m Oct 2023 to a cornerstone investor) and a related-party litigation funding facility (Auracle Group, 2020). Since November 2025, funded by settlement proceeds and option exercises | ### Independent characterisation Analytically, Zuleika has behaved less like an exploration company than like a litigation vehicle with exploration optionality. From 2018 to 2025 its corporate agenda was dominated by its dispute with Vango Mining (later acquired by Catalyst Metals) over its right to earn up to 50% of parts of the Plutonic Gold Mine area, including the K1, K2 and PHB-1 deposits. Exploration spending was modest (cash exploration payments of A$0.78m in FY2025 and A$0.79m in FY2026). With the litigation monetised at A$48m, the company became a cash-and-shares shell with a modest resource base, which explains why a cash-rich peer (CZR, flush from its A$75m Robe Mesa iron ore sale) moved to acquire it within seven months of the settlement. The investment case for remaining ZAG minority holders is now essentially an exchange-ratio decision about holding CZR scrip.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2010
West Perth, Australia
Zinc

Zinc of Ireland Limited

Premium
Information Technology

Zinc of Ireland is a Perth-headquartered, ASX-listed micro-cap that in 2026 transformed from a single-asset Irish zinc explorer into a hybrid "upstream resource plus downstream metals-technology" company. Upstream, it holds the Kildare Zinc-Lead Project on Ireland's Rathdowney Trend — 17 prospecting licences over 595 km² hosting an Inferred Mineral Resource of 11.3 Mt at 9.0% Zn+Pb, located about 40 km southwest of Dublin. Downstream, through the June 2026 acquisition of Netherlands-based Meclex, it owns two proprietary hydrometallurgical processes: ARGO, which targets recovery of zinc, lead, silver and the critical minerals germanium, gallium and indium from zinc leach residue produced by primary zinc smelters; and VOLTA, a low-temperature lead-acid battery recycling process. Neither technology is commercial (ARGO TRL 4; VOLTA TRL 6), and the company has no revenue. The equity story rests on European critical-minerals and battery regulation, industrial partners (Nyrstar; SERI Industrial/FIB) and a refreshed Perth corporate team. --- ### Company's own description (FY2026 Annual Report) The FY2026 Annual Report describes the Group's principal activities as the exploration and evaluation of mineral properties in Europe and, following the acquisition of Meclex, the research and development of metal extraction technologies in Europe. The stated objective is to create long-term shareholder value by developing and commercialising its metal extraction technologies and by exploring and developing its mineral deposits, so as to build and scale a new supply of zinc and other critical metals in Europe and globally. The report candidly states that the Group has not yet demonstrated commercial viability of either its technologies or its mineral deposits, and has not reported any Ore Reserves. Management frames the technologies against four structural pressures facing European heavy industry: extreme energy-price volatility; rising carbon costs and emissions regulation; tightening waste-disposal and recycling legislation; and substantial unrecovered value in zinc, lead, silver and critical minerals lost to residues. ARGO and VOLTA are pitched as low-temperature, low-emission hydrometallurgical alternatives to incumbent high-cost pyrometallurgical processes. ### Business model and revenue model | Dimension | Characterisation | |---|---| | Current revenue | Nil (FY2022–FY2026). Only income is interest and FX (FY2026 finance income A$9,891) | | Intended model — VOLTA | Technology licensing. FY2026 AR states ZMI's strategy is to become a technology licensing company, implementing VOLTA with partners across Europe and globally; discussions with a potential licensee for a greenfield European plant are disclosed. Revenue forms contemplated in the Meclex Incentive Plan definition: sales, operations, licensing fees, royalties | | Intended model — ARGO | Not finalised. Pathway is testwork → pilot plant (targeted early 2027) → commercial demonstration plant → licensing / deployment at smelters; pre-engineering for a 100,000 tpa commercial plant has commenced | | Intended model — Kildare | Conventional mine development (scoping study → PFS → development) and/or sale; ARGO integration intended to improve concentrate value | | Product vs service vs licensing mix | 0% / 0% / 0% today; prospective mix weighted to licensing/royalties (technology) and commodity sales (Kildare, long-dated) | ### Value-chain position ZMI is unusual among ASX juniors in deliberately straddling the zinc value chain: (1) upstream mineral exploration (Kildare zinc-lead-silver, with germanium/gallium potential under investigation); (2) midstream process technology for primary zinc refiners (ARGO, treating zinc leach residue — a waste stream of the roast-leach-electrowinning route); and (3) secondary/circular metals (VOLTA, treating spent lead-acid batteries for secondary lead smelters). The FY2026 AR explicitly notes ARGO has direct application to smelter residues generated from concentrates such as those Kildare would produce. ### Target customers and end-markets | Offering | Customer type | End-market | |---|---|---| | ARGO | Primary zinc smelters/refiners (e.g., Nyrstar — partner and feedstock provider) | Zinc and lead metal; silver; critical minerals (Ge, Ga, In) for semiconductors, fibre optics, infrared optics, LEDs/solar, defence | | VOLTA | Secondary lead smelters / lead-acid battery recyclers (e.g., SERI Industrial/FIB in Italy; several European recyclers expressing interest per FY2026 AR) | Lead-acid battery recycling (automotive SLI, industrial batteries) | | Kildare | Future concentrate buyers (smelters) or acquirers | Zinc and lead concentrates | ### Independent characterisation In substance ZMI is a pre-revenue, early-stage technology-development company with an option-value exploration asset attached. The A$5.58m carrying value of the acquired IP (ARGO A$3.91m; VOLTA A$1.67m) and A$8.96m of capitalised Kildare exploration together make up 77.6% of total assets (FY2026). The company's near-term value drivers are technical (testwork results, pilot/demo plant commissioning, Kildare assays) and contractual (formal extension of the VOLTA cooperation arrangement with FIB/SERI, scope of the Nyrstar ARGO cooperation, first licence agreement), rather than financial. Funding is entirely equity-based and highly dilutive; the capital structure carries a very large overhang of vendor performance rights and incentive options.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2007
Perth, Australia
Zhejiang

Zhejiang Yongan Rongtong Holdings Co., Ltd.

Premium
Information Technology

Zhejiang Yongan Rongtong is a sub-scale woven-fabric manufacturer located in the Keqiao textile cluster of Shaoxing, Zhejiang — one of China's densest concentrations of fabric weaving, dyeing and trading capacity. It produces cotton, polyester, spandex, T/R (polyester-rayon) and fashion woven fabrics, and provides weaving subcontracting services, selling mainly to domestic garment and fabric customers with residual exports to Europe and South America. Revenue has contracted from roughly RMB415 million in the mid-2000s to RMB34.8 million in FY2024 (unaudited), and the company has been loss-making at the operating level throughout the recent five-year period. Its only profitable year in that window (FY2024) was driven by a one-off land resumption gain. Its defining characteristic for investors is its status as a captive satellite of the Zhejiang Yongli conglomerate: repeated unauthorised fund transfers to the parent culminated in suspension in February 2025 and delisting in March 2026. --- ### Company's own description In its latest disclosure documents, the company describes its principal activities as (i) the manufacture, research and development and sale of woven fabrics, and (ii) the provision of woven fabrics subcontracting services (FY2024 unaudited results announcement; circular dated 31 July 2025). Management's FY2024 outlook said the group would concentrate resources on its core PRC textile business, preserve financial strength, and continue measures to raise efficiency, reduce costs and improve liquidity, noting that the difficult environment could persist for at least several more quarters (FY2024 unaudited results, MD&A "Outlook"). ### Independent characterisation | Revenue model component | FY2024 revenue (RMB M) | Share of revenue | Nature | |---|---|---|---| | Product sales — woven fabrics | 32.44 | 93.3% | Manufactured fabric sold per metre/order to garment makers, converters and traders | | Services — weaving subcontracting | 2.34 | 6.7% | Fee-based weaving of customers' yarn/grey goods on the company's looms | | Subscription / licensing | 0 | 0% | None | The business is a commodity-to-semi-specialty weaving operation with negligible pricing power. Its revenue model is almost entirely product sales (woven fabrics: 93.3% of FY2024 revenue) with a small service line (subcontracting fee income: 6.7%). There is no subscription or licensing revenue. A one-off asset-management/investment-advisory revenue line of RMB0.3 million appeared in FY2020 only (Zonebourse/S&P segment data). Source: FY2024 unaudited results announcement, Note 3. **Value-chain position.** The company sits in the midstream of the textile chain: it buys yarn (cotton, polyester, spandex blends, viscose for T/R), weaves fabric, and sells finished or semi-finished woven goods to downstream garment manufacturers and fabric traders. It does not own spinning, garment-making or retail brands. Being located in Keqiao — home to the China Textile City wholesale market — gives it access to dense trading networks but also places it amid intense local competition. **Customer types and end markets.** Customers are B2B fabric buyers: garment manufacturers, converters and trading houses, mostly in the PRC. A single customer ("Customer A") accounted for RMB6.72 million (12.2%) of FY2023 revenue and RMB4.84 million (13.9%) of FY2024 revenue (FY2023 audited results; FY2024 unaudited results, Note 4(c)). End markets are apparel (shirting, trousering, fashion fabrics). Export demand collapsed in FY2024: management reported that domestic woven-fabric sales fell about 29.1% and export sales about 67.3% year on year (FY2024 unaudited results, Business Review). **Former adjacent business.** From August 2019 to May 2024 the group held a 41.67% equity-accounted stake in Beijing Tepia Technology Co., Ltd. (NEEQ: 838941), a water-management information systems and reservoir operations-and-maintenance provider, through its wholly-owned subsidiary Zhejiang Shaoxing Huiju Water Technology Co., Ltd. This was divested to a Yongli-group company for RMB32.5 million (FY2023 audited results, Business Review; FY2024 unaudited results, Note 10).

Revenue$0.0B
Employees98
Market CapN/A
Founded1998
United States, North America
Zeus

Zeus Resources Limited

Premium
Information Technology

Zeus Resources is a pre-revenue, micro-capitalisation mineral explorer that has reinvented itself since a 2024 board spill and ASX suspension. Originally floated in 2013 as a Western Australian uranium explorer — one of the largest minerals IPOs of that year at A$13.5m — Zeus drifted for a decade across uranium, lithium and base-metal tenements before a new, entirely executive board (Alvin Tan, Robert Marusco, Hugh Pilgrim) took control in June 2024. The company now describes its strategy as identifying and developing early-stage, high-grade critical mineral assets in under-explored jurisdictions. Its portfolio has pivoted offshore: the Casablanca Antimony Project in central Morocco (trench intercept 2m @ 22.69% Sb), and from July 2026 the Diaguili Copper-Gold Project in southern Mauritania (staged US$2.0m acquisition). Legacy Australian exposure is reduced to the Kalabity uranium/REE ground in South Australia and the Blue Hill/Wydgee gold-lithium tenements in Western Australia. With roughly A$1.5m of cash at March 2026 and no revenue, Zeus is entirely dependent on equity markets. --- ### What the company does Zeus Resources is a mineral exploration company. It acquires exploration licences (either by application to government or by purchasing companies/licences from vendors), conducts geological work programs (mapping, rock-chip and soil sampling, geophysics, trenching and, prospectively, drilling) and seeks to define mineralisation that can be converted into a JORC-compliant Mineral Resource. Value is realised either by advancing a project towards development or, more commonly for juniors, by selling, farming out or joint-venturing assets once exploration has de-risked them. The company has no production, no customers and no operating revenue. ### Company's own description The FY2025 Annual Report states that the principal activity during the year was the exploration for lithium, potash and other metal resources and the assessment of options for investment in multi-commodity mining assets, and that following the acquisition of the Casablanca Antimony Project the company would explore for antimony in central Morocco [FY2025 Annual Report, Directors' Report]. The H1 FY2026 Interim Report updates this to exploration for antimony and other metal resources [H1 FY2026 Interim Report]. The company's investor materials describe Zeus as a dynamic mineral exploration company focused on identifying and developing early-stage, high-grade critical mineral assets in under-explored jurisdictions with potential to rapidly create shareholder value [Listcorp company profile]. The Chairperson's FY2025 letter frames the strategy around "early-stage, high-grade critical mineral assets in under-explored jurisdictions" and around antimony's designation as a strategic and critical mineral used in defence, energy storage and flame retardants [FY2025 Annual Report, Chairperson's Report]. ### Business model and revenue model | Revenue model element | Share of revenue | Commentary | |---|---|---| | Product sales | 0% | No production | | Services | 0% | None | | Subscription | 0% | None | | Licensing / royalties | 0% (contingent) | Retains a contingent royalty over Mortimer Hills (E09/2147) payable only if Delta Lithium's subsidiary delineates a lithium resource above 0.8% Li2O within four years [FY2025 Annual Report] | | Interest income | 100% of reported "revenue" | FY2025 interest income A$19,156; H1 FY2026 A$4,813 | | Asset sales | Episodic | Mortimer Hills sold for A$150,000 cash (FY2025) | The economic model is that of an exploration "option": cash raised from shareholders is spent on exploration; the equity value depends on discovery news-flow, commodity prices and the ability to keep funding the company. Overheads are low in absolute terms (FY2025 corporate and administrative costs of roughly A$430,000 excluding exploration write-offs and share-based payments) but high relative to exploration spend in years of low activity. ### Value-chain position Zeus sits at the very start of the mining value chain — grassroots to early-stage exploration. None of its projects has a JORC Mineral Resource. The nearest-to-drilling assets are Casablanca (trenching completed on two trenches; maiden drilling originally targeted for Q2 2026 but delayed by permitting) and Diaguili (historical drilling exists; maiden Zeus diamond drilling targeted for Q4 2026). ### Customer types and end-markets (prospective) | Commodity | Prospective end-markets | Relevance to Zeus | |---|---|---| | Antimony | Flame retardants, lead-acid batteries, defence munitions/primers, solar-glass (photovoltaics), semiconductors | Casablanca (Morocco) — core asset FY2025–FY2026 | | Copper / gold | Electrification, construction, grid; gold as monetary/investment metal | Diaguili (Mauritania) — core asset from July 2026 | | Uranium | Nuclear fuel | Kalabity (SA); legacy WA uranium (WA mining moratorium noted by company) | | Rare earths, lithium | Permanent magnets, batteries | Kalabity (SA), Blue Hill (WA) | | Gold, base metals | Investment, industrial | Blue Hill/Wydgee (WA) | ### Independent characterisation Zeus is best characterised as a shell-like listed vehicle being re-capitalised by a corporate-finance-oriented board around a sequence of offshore project acquisitions. All three directors have backgrounds in corporate advisory, capital raising and ASX listings rather than geology; technical work is outsourced (Ashgill in Morocco; independent Competent Person Phil Jones for Australia; Bakr Khudeira — also the Casablanca vendor and a substantial shareholder — as Competent Person for Morocco). The model is capital-light but highly dilutive: shares on issue rose from 459.3m (June 2024) to 717.7m (December 2025), before a further placement in 2026, while the share price fell from about 1.2 cents (June 2025) to around 0.5 cents (August 2026). The strategic pivot from Morocco antimony to Mauritanian copper-gold within roughly twelve months of completing the Casablanca deal suggests opportunism around commodity cycles (antimony supply shock, then record copper prices) rather than a long-duration single-asset strategy.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2009
South Perth, Australia
Zenith

Zenith Minerals Limited

Premium
Information Technology

Zenith Minerals is a Perth-based, pre-revenue mineral explorer whose investment case has been distilled over 2024–2026 from a scattered multi-commodity portfolio into a focused Western Australian gold development story. Its flagship, the 100%-owned Consolidated Dulcie Gold Project in the Southern Cross–Forrestania greenstone belt, hosts a JORC (2012) Inferred Mineral Resource of 21.3 Mt at 1.0 g/t Au for 675,000 oz, predominantly on granted mining leases and within trucking distance of third-party mills. A second gold asset, Red Mountain in Queensland, is an early-stage intrusion-related gold system with discovery-scale intercepts. Lithium (Rio/Split Rocks, Waratah Well), a 25% free-carried interest in the Earaheedy zinc JV, and minority equity stakes provide optionality. Zenith has no revenue, depends on equity funding, and is now effectively under the control of Forrestania Resources following a takeover that the Takeovers Panel found was conducted in unacceptable circumstances. Its standalone future is therefore highly uncertain. --- ### What the company does Zenith Minerals is a junior exploration company. It acquires mineral tenure, conducts geological, geochemical and geophysical work, drills, and — where successful — defines JORC-compliant Mineral Resources with a view to either developing a mine or monetising assets through sale, joint venture or corporate transaction. It has never operated a mine in its own right. ### The company's own description In its 2026 filings, Zenith describes itself as an Australian gold and lithium exploration and development company focused on advancing its flagship Consolidated Dulcie Gold Project in Western Australia (Strategic Review announcement, 7 May 2026; M77/599 completion announcement, 11 May 2026). The FY2025 Annual Report (Managing Director's Report) frames the company as having been repositioned around gold as its near-term value driver, having exited non-core assets and redeployed capital, while retaining disciplined, selective exposure to battery minerals. The May 2026 investor presentation styled the company a "Strategic WA Gold Developer". ### Independent characterisation Zenith is best characterised as a single-asset gold resource developer with an attached discovery option and a basket of passive optionality. The economic value of the company rests overwhelmingly on Dulcie's 675 koz Inferred resource. Inferred resources carry the lowest geological confidence category under JORC and cannot be converted to Ore Reserves without upgrade drilling and studies; no scoping, pre-feasibility or feasibility study has been published for Dulcie. Management itself conceded in the June 2026 quarterly that the greatest challenge had shifted from finding gold to securing a processing solution and development funding beyond the means of a company of Zenith's size — the explicit rationale for the Forrestania transaction. ### Business model and revenue model | Element | Description | Source | |---|---|---| | Revenue model | No product, service, subscription or licensing revenue. "Revenue" reported by data providers consists of interest, grants, sundry income and occasional option/asset-sale income | StockAnalysis (FY2021–FY2025); Appendix 5B | | Product vs service vs subscription vs licensing mix | 0% / 0% / 0% / 0% — not applicable | Analyst assessment | | Funding model | Equity placements, rights issues, option exercises, asset/equity sales, government co-funding grants | Annual reports; Appendix 5B | | Monetisation pathways | (1) Development of Dulcie (likely via toll treatment); (2) sale of assets; (3) joint ventures/free-carry structures (e.g., Earaheedy); (4) corporate takeover (now in progress) | June 2026 Quarterly | | Value chain position | Upstream — exploration and resource definition, the earliest and highest-risk stage of the mining value chain | Analyst assessment | | Customer types | None currently. Prospective future customers: gold refiners (doré) if a mine is developed, or toll-treatment counterparties; lithium concentrate offtakers in the long term | Analyst assessment | | End markets | Gold (precious metals/investment/jewellery), lithium (battery supply chain), zinc-lead-silver (industrial base metals) | Company descriptions | ### FY2026 cash deployment (proxy for business activity) | Line item (FY2026, A$'000) | Amount | Source | |---|---|---| | Exploration & evaluation payments | 6,988 | June 2026 Appendix 5B (YTD 12 months) | | Staff costs | 1,155 | Same | | Administration and corporate costs | 1,626 | Same | | Interest received | 163 | Same | | Government grants and tax incentives | 169 | Same | | Receipts from customers | 8 | Same | | Net operating cash flow | (9,631) | Same | | Proceeds from disposal of tenements (Kavaklitepe interest) | 819 | Same | | Equity issue proceeds | 11,180 | Same | | Option exercise proceeds | 1,747 | Same |

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2006
West Perth, Australia
Zeder

Zeder Investments Ltd.

Premium
Information Technology

Zeder Investments is a Stellenbosch-based, JSE-listed investment holding company in the PSG Group stable. It was created in 2006 to take long-term strategic stakes across the South African agribusiness value chain. At its peak (FY2018–FY2020) the portfolio was valued at R11–14bn and included Pioneer Foods, Kaap Agri, Capespan, The Logistics Group, Quantum Foods, Agrivision Africa and Zaad. Since 2020 Zeder has run a deliberate value-realisation programme. It sold or unbundled almost every asset and returned more than R8.6bn to shareholders through special dividends and unbundlings. At 28 February 2026 its sum-of-the-parts (SOTP) value was R2.316bn, or R1.50 per share. This consisted almost entirely of Zaad, a specialist seed and agrochemical group, and a 48.6% look-through stake in Türkiye's May Seed. The sale of Zaad (excluding May Seed and other excluded assets) to a consortium of WIPHOLD, the PIC, Phatisa and the IDC for up to R1.39bn is awaiting regional competition approvals. Zeder is therefore best characterised as a late-stage liquidation and distribution vehicle with one residual foreign asset. --- ### Company's own description In its FY2026 results Zeder describes itself as an investor in the broad agribusiness and related industries, with a total SOTP value of R2.3bn at 28 February 2026. Its stated objective is to maximise long-term wealth for shareholders, and its key performance benchmark is SOTP value per share (Zeder FY2026 reviewed results, 23 April 2026). Earlier disclosures (FY2024) describe a corporate role of assisting with portfolio and investee strategies and overseeing capital allocation to ensure sustainable investment returns. ### Business model and accounting basis Zeder meets the definition of an Investment Entity under IFRS 10. It does not consolidate its portfolio companies. Instead it measures them at fair value through profit or loss under IFRS 9 and IFRS 13, and all investments are Level 3 (unlisted) as at FY2026. As a result: **"Revenue":** at the reported level consists of investment income (interest on cash and shareholder loans, plus dividends from portfolio companies). It was R144m in FY2026 (continued R15m + discontinued R129m) and R536m in FY2025 (re-presented), the latter inflated by R484m of special dividends from Pome Investments. **Value creation (or destruction):** shows up mainly as fair value gains or losses on investments: a net R479m loss in FY2026 and a net R652m loss in FY2025. **Costs:** are head-office marketing, administration and other expenses (R38m in FY2026) plus transaction costs (R39m in FY2026, including R28m paid to PSG Capital for corporate finance work). **Cash returns:** to shareholders come through special dividends, funded by realisations, rather than ordinary dividends. The revenue model is therefore neither product, service, subscription nor licensing. It is capital appreciation plus investment income from strategic, mostly controlling stakes in private agribusinesses. The portfolio companies themselves (chiefly Zaad) earn product revenue from selling proprietary and distributed seed varieties and agrochemicals. ### Portfolio composition at 28 February 2026 (FY2026 SOTP) | Component | Interest (%) | Value (Rm) | Share of investments (%) | Valuation method | |---|---|---|---|---| | Zaad (excluding Zaad International / May Seed) – held for sale | 97.2 | 1094 | 61 | Agreed transaction value | | Zaad International (May Seed) – continued investment | 97.2 (look-through 48.6% of May Seed) | 694 | 39 | EV/EBITDA multiple | | Pome Investments – held for sale | 87.1 | 8 | 0.4 | Net asset value | | Total investments and assets held for sale | — | 1796 | 100 | — | | Cash and cash equivalents | — | 231 | — | — | | Other net assets and liabilities (mainly R361m Zaad shareholder loan claim) | — | 289 | — | — | | SOTP value | — | 2316 | — | — | | SOTP value per share (R) | — | 1.50 | — | — | Source: Zeder FY2026 reviewed results, Annexure A. ### Value-chain position, customers and end-markets **Historical position (to 2020):** Zeder spanned the agri value chain from inputs (Zaad seed and chemicals), through primary production and fruit marketing (Capespan), logistics and terminals (The Logistics Group), agri-retail and fuel (Kaap Agri), to FMCG (Pioneer Foods, Quantum Foods). **Current position:** almost entirely agri-inputs. Zaad owns, develops, imports and distributes agricultural seed (field crops, oilseeds, forage, vegetables) and agrochemicals and fertilisers. Its customers are commercial and emerging farmers, distributors, co-operatives and dealers in South Africa, East Africa, Europe and the Middle East. May Seed serves Turkish and regional seed markets. **End-markets:** grain and oilseed production (maize, soybean, sunflower, canola), pasture and forage, vegetable production, and crop protection. Demand is driven by planted area, weather, commodity prices, farmer financial health and currency. ### Independent characterisation Zeder should no longer be analysed as a going-concern agribusiness compounder. It is a realisation vehicle. Over FY2021–FY2026 it converted a diversified portfolio into cash and returned the proceeds, and the remaining value depends on three things: 1. completing the Zaad sale (R1.029bn equity value plus R361m loan claim to Zeder); 2. how much of the proceeds the board distributes versus retains against warranty exposure (capped at 30% of consideration); and 3. the eventual monetisation of the 48.6% look-through May Seed stake (R694m, valued at 5.7x EV/EBITDA after a 35% company-specific and 20% marketability discount). The board has not articulated any new-investment strategy.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2006
Stellenbosch, South Africa
Zarclear

Zarclear Holdings Limited

Premium
Information Technology

Zarclear Holdings is a small South African permanent-capital investment holding company. It was spun out of Peregrine Holdings in 2017 as Sandown Capital. In late 2018 a new management team led by Warren Chapman, an executive linked to the Peresec / Legae Peresec brokerage group, took control and changed its mandate. The company pursues two strategies. The first is a liquid, NAV-focused portfolio, now concentrated in a Peresec-issued equity index basket-linked note referencing Peregrine Capital hedge fund strategies and in a 23.8% stake in the unlisted investment company African Phoenix Investments. The second is a small, earnings-focused cluster of South African financial-market infrastructure and regulatory-technology businesses. The flagship of that cluster is a 60%-owned securities lending intermediary with an R8.8bn loan book. Zarclear has paid back capital, delisted, and is now effectively controlled by a concert group of related holders that owns 91%. Following a 2023 share consolidation and conversion to private-company form, it operates as a closely held vehicle with minimal public disclosure. --- ### Company's own description In its 2023 response circular, Zarclear describes itself as an investment holding company that uses its status as a permanent capital vehicle to invest in high-quality opportunities, with a focus on financial market infrastructure companies that benefit from liquid, flexible capital, a broad shareholder base, sector expertise and management networks [S5]. Its website headline reads "Focused on financial market infrastructure" [S21]. The FY2022 directors' report sets out a two-leg strategy [S4]: **Leg 1:** a portfolio of listed equities, contracts for difference, fixed income and other instruments that provides liquidity, transparency and market-related returns, and whose liquidity supports leg two. **Leg 2:** developing, investing in and managing market-infrastructure and regulation-technology operations. Targets include regulated exchanges, trade repositories, clearing houses, securities depositories and investment and technology platforms, mainly in South Africa. ### Independent characterisation In practice Zarclear operates as a closed-end, NAV-driven holding company with three types of exposure: 1. **Managed liquid capital.** Through FY2021 this was Stenprop / Industrials REIT shares, hedge funds and a directly managed portfolio. By June 2022 it had been consolidated into a single Equity Index Basket Linked Note (EIBL) valued at R438.2m. The note was issued by related party Peresec Prime Brokers and its return is linked mainly to a Peregrine Capital-managed hedge fund portfolio [S4]. 2. **A strategic cross-holding.** Zarclear holds 335,435,546 shares (about 23.8%) in African Phoenix Investments Limited, valued at R300.2m at 30 Jun 2022. African Phoenix in turn holds about 29% of Zarclear (excluding treasury shares) [S4]. 3. **Operating market-infrastructure subsidiaries and stakes.** These are Zarclear Securities Lending (60%), Peresec Technology Solutions (100%; appears to be the renamed Zarclear Proprietary, see §5), African Phoenix A2X Proprietary Limited (100%; holds an effective 6.97% of the A2X exchange, carried at nil), and a 5.47% stake in Equity Express Securities Exchange [S4]. **Revenue model.** Group "income" has two parts: **Investment income:** realised and unrealised fair-value gains, dividends and interest on portfolio investments. This dominates, at R295.7m of R340.0m total income in FY2022 (87%). **Fee income:** technology services and securities lending intermediation fees from the infrastructure subsidiaries, R44.3m in FY2022 (13%) [S4]. There is no product sales, subscription or licensing revenue in the conventional sense. The fee business is service- and intermediation-based. **Value-chain position.** Zarclear supplies capital (and, through subsidiaries, intermediation and technology services) to South Africa's capital-markets plumbing. Zarclear Securities Lending sits between lenders of scrip (typically banks and large securities holders) and borrowers (typically short sellers). It borrows and on-lends securities under Global Master Securities Lending Agreements (GMSLAs) and does not borrow for its own account [S4]. **Customer types.** Securities lenders and borrowers, financial services firms buying trading technology and advisory services [S1], and the wider South African institutional market. A material share of activity involves related parties. Peresec Prime Brokers is both service provider and client, and holds the group's stockbroking accounts and the EIBL [S3, S4]. **End-markets.** South African equity trading and securities financing, alternative exchanges (A2X, Equity Express), and hedge-fund-style equity strategies.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2000
Sandton, South Africa
Youfoodz

Youfoodz Holdings Limited

Premium
Information Technology

Youfoodz is Australia's best-known branded fresh, chilled, ready-made meal business. It was founded in Brisbane in 2012 by Lance Giles and grew from a founder-run kitchen into a vertically integrated manufacturer and omni-channel distributor. At the time of its acquisition it produced roughly 400,000 meals, 80,000 snacks and 45,000 drinks per week across three Brisbane facilities. It sold direct to consumers through a home-delivery platform with a database of more than 850,000 customers. It also sold wholesale to supermarkets, independent grocers, petrol and convenience chains, gyms, and corporate and government customers. Today Youfoodz is a captive brand and manufacturing asset inside the world's largest meal-kit group. Its strategic fortunes now depend on HelloFresh's capital allocation to the RTE category. --- **Company's own description (FY2021 / scheme-period ASX disclosures).** In its October 2021 announcements, Youfoodz described itself as a specialist producer and distributor of affordable, high-quality fresh ready-made meals and other convenience foods for residential (home delivery), retail and corporate customers. It said it had delivered more than 60 million ready-made meals since 2012. It marketed through an omni-channel model with two parts. The first was a home-delivery (B2C) offering. The second was a business-to-business (B2B) offering to supermarkets, independent grocers, petrol and convenience retailers, and corporate and government customers. The company highlighted its three Brisbane production facilities and what it called a scalable, proprietary manufacturing technology for optimising production and supply-chain management (Youfoodz ASX Announcement, 27 October 2021). **Business model.** Youfoodz is a vertically integrated food manufacturer with its own consumer brand and its own direct channel. It designs menus in-house, buys fresh produce (management said nearly 90% of ingredients came from local farmers; Inside FMCG, May 2022), cooks and packs at scale in chilled form, and distributes through two routes: **B2C (home delivery / direct-to-consumer):** Consumers order online from a rotating menu of single-serve chilled meals, snacks and drinks. Delivery is to metro areas, with a stated three-day timeframe for regions outside Brisbane, Sydney and Melbourne and air freight for more remote areas (Business News Australia, Nov 2020). Before the acquisition, Giles described the platform as an order-whenever-you-like model rather than a locked subscription (Business News Australia, Nov 2020). HelloFresh said after the deal that it would make the brand increasingly available through its subscription platform (FoodBev, July 2021). **B2B (wholesale / retail):** Branded products are sold through supermarkets, grocery retailers, petrol and convenience (P&C) stations, gyms, corporates and government organisations (Fresh Equities profile; Business News Australia, April 2021). **Revenue model mix.** About 100% product revenue (food sales). There is no licensing or service revenue of note. The B2C channel is transactional and recurring in behaviour (repeat ordering) rather than contracted subscription revenue, although subscription mechanics were introduced under HelloFresh ownership. B2C was the larger and faster-growing channel. In Q3 FY2021, DTC gross revenue was A$34.6m, and in FY2021 B2C revenue grew almost 35% while B2B fell 4.4% (Business News Australia, April 2021; InDaily Qld, August 2021). An exact full-year B2C/B2B split in dollars is not publicly disclosed in the sources reviewed. **Value chain position.** Youfoodz spans product development, manufacturing, branding, direct-to-consumer marketing and last-mile fulfilment management. It sits between primary produce suppliers and end consumers, competing with both meal-kit companies (which sell ingredients for home cooking) and supermarket own-label chilled meals. **Customer types and end markets.** **Independent characterisation.** Youfoodz was a scaled but sub-profitable branded manufacturer with a structurally attractive consumer franchise and an under-invested asset base. Three fragmented, capacity-constrained Brisbane sites capped output at about 420,000 meals per week (Business News Australia, Sept 2021). At listing, the equity story depended on consolidating into a purpose-built automated plant, which management said would be the step change into profit. The COVID-era pattern of B2C strength and B2B weakness exposed the earnings fragility of a business with thin EBITDA margins (FY2021 EBITDA about A$1m on about A$146m net revenue). That left it vulnerable to a strategic acquirer with a lower cost of capital. Inside HelloFresh, Youfoodz is best seen as the RTE production platform and brand for ANZ, analogous to Factor in the US.

Revenue$0.1B
EmployeesN/A
Market CapN/A
Founded2012
Berrinba, Australia

Page 199 of 482

1…198199200…482

Page 199 of 482

Go to page
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo